Use of aerosolized levofloxacin for treating cystic fibrosis

The invention relates to methods for treating cystic fibrosis comprising administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. The invention relates in particular to administering the aerosol solution to a human wherein...

Full description

Saved in:
Bibliographic Details
Main Authors MORGAN, ELIZABETH E, GRIFFITH, DAVID C, LOUTIT, JEFFEREY S, LOMOVSKAYA, OLGA, DUDLEY, MICHAEL N
Format Patent
LanguageEnglish
Published 22.03.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to methods for treating cystic fibrosis comprising administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. The invention relates in particular to administering the aerosol solution to a human wherein said human has a pulmonary infection comprising P.
Bibliography:Application Number: AU20100289326